Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study

Renée M.G. Verdiesen & Marjanka K. Schmidt et al.

Abstract

Background:

It is unclear if established breast cancer risk factors exert similar causal effects across hormone receptor breast cancer subtypes. We estimated and compared causal estimates of height, body mass index (BMI), type 2 diabetes, age at menarche, age at menopause, breast density, alcohol consumption, regular smoking, and physical activity across these subtypes.

Methods:

We used a two-sample Mendelian randomization approach and selected genetic instrumental variables from large-scale genome-wide association studies. Publicly available summary-level Breast Cancer Association Consortium data (n = 247,173; 133,384 cases, 113,789 controls) for the following subtypes were included: luminal A–like (45,253 cases), luminal B–/HER2-negative–like (6,350 cases), luminal B–like (6,427 cases), HER2-enriched (2,884 cases), and triple-negative (8,602 cases). We employed multiple Mendelian randomization methods to evaluate the strength of causal evidence for each risk factor–subtype association.

Results:

Collectively, our analyses indicated that increased height and decreased BMI are probable causal risk factors for all five subtypes. For the other risk factors, the strength of evidence for causal effects differed across subtypes. Heterogeneity in the magnitude of causal effect estimates for age at menopause and breast density was explained by null findings for triple-negative tumors. Regular smoking was the sole risk factor for which there was no evidence of a causal effect on any subtype.

Conclusions:

This study suggests that established breast cancer risk factors differ across hormone receptor subtypes.

Impact:

Our results are valuable for the development of primary prevention strategies, improvement of breast cancer risk stratification in the general population, and identification of novel breast cancer risk factors.

Funding
Cancer Research UK Grant 10692Ovarian Cancer Research Fund (OCRF) FundingBreast Cancer Research Foundation (BCRF) FundingWellcome Trust (WT) Grant 225790/Z/22/ZCancer Research UK Grant 16565Cancer Research UK Grant 20861Horizon 2020 Framework Programme (H2020) Grant 633784Seventh Framework Programme (FP7) Grant 223175 (HEALTH-F2-2009-223175)Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)Cancer Research UK (CRUK) Grant C5047/A15007Discovery, Biology and Risk of Inherited Variants in Breast CancerGenome Canada (GC) Grant GPH-129344Wellcome Trust Grant 100114Cancer Research UK (CRUK) Grant C12292/A20861The Dutch Ministry of Health, Welfare and Sport FundingCancer Research UK Grant 10710Medical Research Council (MRC) Grant MC_UU_00040/01Cancer Research UK Grant 12014Fondation du cancer du sein du Québec (FCSQ) FundingMedical Research Council (MRC) Grant MC_UU_00002/7Cancer Research UK (CRUK) Grant C5047/A8384Cancer Research UK Grant 11174Cancer Research UK Grant PPRPGM-Nov20\100002U.S. Department of Defense (DOD) Grant W81XWH-10-1-0341A genome-wide association study for breast cancer in BRCA1 mutation carriersCancer Research UK (CRUK) Grant C8197/A16565Cancer Research UK (CRUK) Grant C1287/A10710Cancer Research UK (CRUK) Grant C1287/A10118A genome-wide association study for breast cancer in BRCA1 mutation carriersHorizon 2020 Framework Programme (H2020) Grant 634935Elucidating Loci Involved in Prostate Cancer SuceptibilityCancer Research UK (CRUK) Grant C12292/A11174Susan G. Komen (SGK) FundingCancer Research UK Grant 15007Cancer Research UK (CRUK) Grant C1287/A16563Antonie van Leeuwenhoek Foundation FundingCanadian Institutes of Health Research (CIHR) Grant CRN-87521Cancer Research UK Grant 16563National Institutes of Health (NIH) Grant X01HG007492KWF Kankerbestrijding (DCS) FundingCancer Research UK (CRUK) Grant C5047/A10692Ministère de l'Économie, de la Science et de l'Innovation - Québec (MESI) Grant PSRSIIRI-701Gray Foundation FundingCancer Research UK Grant 10118Cancer Research UK (CRUK) Grant C1281/A12014Discovery, Biology and Risk of Inherited Variants in Breast CancerFondation du cancer du sein du Québec FundingElucidating Loci Involved in Prostate Cancer SuceptibilitySusan G. Komen FundingBreast Cancer Research Foundation FundingOvarian Cancer Research Fund FundingKWF Kankerbestrijding Funding

National Institutes of Health (NIH)

CA148112

NCI NIH HHS

U19 CA148112

NCI NIH HHS

U19 CA148065

National Institutes of Health (NIH)

CA128978

NCI NIH HHS

R01 CA128978

NCI NIH HHS

U19 CA148537

National Institutes of Health (NIH)

CA148065

National Institutes of Health

CA128978

National Institutes of Health

U19 CA148537

National Institutes of Health

CA148065

National Institutes of Health

CA148112